✦ LIBER ✦

Lack of efficacy of maintenance interferon: Results of the HALT-C trial

✍ Scribed by Bruce R. Bacon

Book ID: 107538458
Publisher: Springer
Year: 2009
Tongue: English
Weight: 191 KB
Volume: 11
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-009-0001-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of high-do

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C

✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.

Quantitative tests of liver function mea

Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial

✍ G. T. EVERSON; M. L. SHIFFMAN; J. C. HOEFS; T. R. MORGAN; R. K. STERLING; D. A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Evolution of hepatic steatosis in patien

Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial

✍ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo

The potential lack of comparability betw

The potential lack of comparability between interim and final results of cancer clinical trials

✍ Stephen K. Carter 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 142 KB

Lack of benefit of dietary advice to men

Lack of benefit of dietary advice to men with angina: results of a controlled trial

✍ Burr, M L; Ashfield-Watt, P A L; Dunstan, F D J; Fehily, A M; Breay, P; Ashton, 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Final results of a double-blind, placebo

Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis

✍ Paul J. Pockros; Lennox Jeffers; Nezam Afdhal; Zachary D. Goodman; David Nelson; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 2 views

## Interferon-␥1b (IFN-␥1b ) is a pleiotropic cytokine that displays antifibrotic, antiviral, and antiproliferative activity. A total of 502 patients with compensated liver disease and an Ishak fibrosis score of 4-6 were randomized in a double-blind, placebo-controlled study, and 488 of these pati